20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
20 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers
贏家
• CytoSorbents, Inc. (NASDAQ:CTSO) stock rose 101.30% to $9.28 during Wednesday's pre-market session.
• T2 Biosystems, Inc. (NASDAQ:TTOO) shares rose 97.67% to $0.77.
· T2生物系統公司納斯達克股票代碼：TTOO)股價上漲97.67%，至0.77美元。
• Milestone Pharmaceuticals, Inc. (NASDAQ:MIST) shares moved upwards by 55.88% to $2.65. According to the most recent rating by Jefferies, on Mar 25, the current rating is at Hold.
· 里程碑製藥公司公司納斯達克(Youku)股價上漲55.88%，至2.65美元。根據傑富瑞3月25日的最新評級，目前的評級為持有。
• Tiziana Life Sciences, Inc. (NASDAQ:TLSA) stock rose 16.67% to $2.10.
·Tiziana生命科學公司納斯達克(TLSA)股價上漲16.67%，至2.10美元。
• Kitov Pharma, Inc. (NASDAQ:KTOV) shares surged 11.67% to $0.27.
· 基托夫製藥公司公司納斯達克(Tmall：KTOV)股價飆升11.67%，至0.27美元。
• Neuronetics, Inc. (NASDAQ:STIM) stock moved upwards by 10.96% to $1.62.
· 神經病學公司納斯達克(股票代碼：STIM)股價上漲10.96%，至1.62美元。
• Onconova Therapeutics, Inc. (NASDAQ:ONTX) shares rose 8.90% to $0.40.
· Onconova治療公司公司納斯達克(Sequoia Capital：ONTX)股價上漲8.90%，至0.4美元。
• ADMA Biologics, Inc. (NASDAQ:ADMA) shares increased by 7.64% to $3.10. The most recent rating by H.C. Wainwright, on Mar 16, is at Buy, with a price target of $12.
• Adamis Pharmaceuticals, Inc. (NASDAQ:ADMP) shares moved upwards by 5.13% to $0.41.
· Adamis製藥公司公司納斯達克(Sequoia Capital：ADMP)股價上漲5.13%，至0.41美元。
• Novo Nordisk, Inc. (NYSE:NVO) shares rose 5.01% to $53.07. The most recent rating by KeyBanc, on Feb 19, is at Overweight, with a price target of $18.
·諾和諾德公司(紐約證券交易所代碼：NVO)股價上漲5.01%，至53.07美元。KeyBanc在2月19日的最新評級為加碼，目標價為18美元。
Losers
失敗者
• Immutep, Inc. (NASDAQ:IMMP) stock declined 47.85% to $0.97 during Wednesday's pre-market session.
· 不變的公司納斯達克(Sequoia Capital：IMMP)股價週三盤前下跌47.85%至0.97美元。
• IMAC Holdings, Inc. (NASDAQ:IMAC) shares plummeted 32.53% to $3.34. According to the most recent rating by Dawson James, on Jan 14, the current rating is at Neutral.
· IMac控股公司公司納斯達克(Youku)股價暴跌32.53%，至3.34美元。根據道森·詹姆斯1月14日的最新評級，目前的評級為中性。
• ThermoGenesis Holdings, Inc. (NASDAQ:THMO) shares plummeted 10% to $4.50.
· 生熱控股公司納斯達克(THMO：THMO)股價暴跌10%，至4.5美元。
• Tonix Pharmaceuticals, Inc. (NASDAQ:TNXP) stock decreased by 8.08% to $0.91.
·Tonix製藥公司(納斯達克：TNXP)股價下跌8.08%，至0.91美元。
• Capricor Therapeutics, Inc. (NASDAQ:CAPR) shares declined 7.95% to $1.62.
· 卡布裡卡治療公司公司納斯達克(Tmall：CAPR)股價下跌7.95%，至1.62美元。
• Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock decreased by 7.55% to $0.49.
· 衛報健康科學公司納斯達克股票代碼：GHSI)股票下跌7.55%，至0.49美元。
• Akers Biosciences, Inc. (NASDAQ:AKER) shares fell 7.17% to $2.20.
· Akers生物科學公司納斯達克(Tmall：AKR)股價下跌7.17%，至2.20美元。
• Aytu BioScience, Inc. (NASDAQ:AYTU) stock declined 7.04% to $1.85.
· 艾圖生物科學公司納斯達克(Alipay：AYTU)股價下跌7.04%，至1.85美元。
• GenMark Diagnostics, Inc. (NASDAQ:GNMK) stock decreased by 7.03% to $4.10. The most recent rating by Needham, on Mar 3, is at Buy, with a price target of $11.
· Genmark診斷公司(納斯達克代碼：GNMK)股票下跌7.03%，至4.10美元。Needham在3月3日的最新評級為Buy，目標價為11美元。
• Bellerophon Therapeutics, Inc. (NASDAQ:BLPH) shares fell 6.96% to $8.56.
· 貝勒羅芬治療公司公司納斯達克(Sequoia Capital：BLPH)股價下跌6.96%，至8.56美元。
譯文內容由第三人軟體翻譯。